Home LiteratureArticle Details
PMID: 17540599 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.

Molecular cell ·Vol. 26 ·No. 5 ·2007-06-08 ·Pages 745-52

Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT

Abstract

The p53 tumor suppressor protein is a critical regulator of the cellular response to cancer-initiating insults such as genotoxic stress. In this report, we demonstrate that microRNAs (miRNAs) are important components of the p53 transcriptional network. Global miRNA expression analyses identified a cohort of miRNAs that exhibit p53-dependent upregulation following DNA damage. One such miRNA, miR-34a, is commonly deleted in human cancers and, as shown here, frequently absent in pancreatic cancer cells. Characterization of the miR-34a primary transcript and promoter demonstrates that this miRNA is directly transactivated by p53. Expression of miR-34a causes dramatic reprogramming of gene expression and promotes apoptosis. Much like the known set of p53-regulated genes, miR-34a-responsive genes are highly enriched for those that regulate cell-cycle progression, apoptosis, DNA repair, and angiogenesis. Therefore, it is likely that an important function of miR-34a is the modulation and fine-tuning of the gene expression program initiated by p53.

MeSH Terms
Apoptosis/genetics,physiology Base Sequence Cell Line, Tumor DNA Damage Gene Expression Humans MicroRNAs/genetics,metabolism Pancreatic Neoplasms/genetics,metabolism Promoter Regions, Genetic RNA, Neoplasm/genetics,metabolism Transcriptional Activation Tumor Suppressor Protein p53/metabolism
Chemicals
MicroRNAs RNA, Neoplasm TP53 protein, human Tumor Suppressor Protein p53
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Chang Tsung-Cheng
The McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Wentzel Erik A
Kent Oliver A
Ramachandran Kalyani
Mullendore Michael
Lee Kwang Hyuck
Feldmann Georg
Yamakuchi Munekazu
Ferlito Marcella
Lowenstein Charles J
Arking Dan E
Beer Michael A
Maitra Anirban
Mendell Joshua T
References (49)
49 references, click to expand
  1. Death and decoy receptors and p53-mediated apoptosis.
    Leukemia. 2000 Aug;14(8):1509-13 PMID: 10942251
  2. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
    Oncogene. 2007 Jul 26;26(34):5017-22 PMID: 17297439
  3. Surfing the p53 network.
    Nature. 2000 Nov 16;408(6810):307-10 PMID: 11099028
  4. On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data.
    J Comput Biol. 2001;8(1):37-52 PMID: 11339905
  5. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.
    Bioinformatics. 2003 Jan 22;19(2):185-93 PMID: 12538238
  6. Microsatellite analysis at 1p36.3 in malignant melanoma of the skin: fine mapping in search of a possible tumour suppressor gene region.
    Melanoma Res. 2003 Feb;13(1):29-33 PMID: 12569282
  7. Immortalization with telomerase of the Nestin-positive cells of the human pancreas.
    Biochem Biophys Res Commun. 2003 Feb 21;301(4):1038-44 PMID: 12589817
  8. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo.
    Nat Genet. 2003 Mar;33(3):396-400 PMID: 12567186
  9. DAVID: Database for Annotation, Visualization, and Integrated Discovery.
    Genome Biol. 2003;4(5):P3 PMID: 12734009
  10. Exploration, normalization, and summaries of high density oligonucleotide array probe level data.
    Biostatistics. 2003 Apr;4(2):249-64 PMID: 12925520
  11. The Bcl-2-regulated apoptotic pathway.
    J Cell Sci. 2003 Oct 15;116(Pt 20):4053-6 PMID: 12972498
  12. The nuclear RNase III Drosha initiates microRNA processing.
    Nature. 2003 Sep 25;425(6956):415-9 PMID: 14508493
  13. The inhibitors of apoptosis: there is more to life than Bcl2.
    Oncogene. 2003 Nov 24;22(53):8568-80 PMID: 14634619
  14. Control of apoptosis by p53.
    Oncogene. 2003 Dec 8;22(56):9030-40 PMID: 14663481
  15. On parametric empirical Bayes methods for comparing multiple groups using replicated gene expression profiles.
    Stat Med. 2003 Dec 30;22(24):3899-914 PMID: 14673946
  16. MicroRNAs: genomics, biogenesis, mechanism, and function.
    Cell. 2004 Jan 23;116(2):281-97 PMID: 14744438
  17. MicroRNAs: small RNAs with a big role in gene regulation.
    Nat Rev Genet. 2004 Jul;5(7):522-31 PMID: 15211354
  18. The functions of animal microRNAs.
    Nature. 2004 Sep 16;431(7006):350-5 PMID: 15372042
  19. Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise.
    Nat Genet. 2004 Oct;36(10):1073-8 PMID: 15448691
  20. Identification of mammalian microRNA host genes and transcription units.
    Genome Res. 2004 Oct;14(10A):1902-10 PMID: 15364901
  21. MicroRNA genes are transcribed by RNA polymerase II.
    EMBO J. 2004 Oct 13;23(20):4051-60 PMID: 15372072
  22. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
    Cancer Res. 1992 Feb 15;52(4):770-4 PMID: 1346584
  23. Two distinct regions involved in 1p deletion in human primary breast cancer.
    Cancer Res. 1993 May 1;53(9):1990-4 PMID: 8097672
  24. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors.
    Int J Cancer. 1995 Jun 22;64(3):207-10 PMID: 7622310
  25. p21 is necessary for the p53-mediated G1 arrest in human cancer cells.
    Cancer Res. 1995 Nov 15;55(22):5187-90 PMID: 7585571
  26. Tumor-suppressor p53: implications for tumor development and prognosis.
    J Clin Oncol. 1998 Sep;16(9):3158-68 PMID: 9738588
  27. Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia.
    Blood. 1998 Nov 1;92(9):3405-9 PMID: 9787180
  28. Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
    Science. 1998 Nov 20;282(5393):1497-501 PMID: 9822382
  29. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs.
    RNA. 2004 Dec;10(12):1957-66 PMID: 15525708
  30. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.
    Nature. 2005 Feb 17;433(7027):769-73 PMID: 15685193
  31. A custom microarray platform for analysis of microRNA gene expression.
    Nat Methods. 2004 Oct;1(1):47-53 PMID: 15782152
  32. c-Myc-regulated microRNAs modulate E2F1 expression.
    Nature. 2005 Jun 9;435(7043):839-43 PMID: 15944709
  33. MicroRNA biogenesis: coordinated cropping and dicing.
    Nat Rev Mol Cell Biol. 2005 May;6(5):376-85 PMID: 15852042
  34. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis.
    Nature. 2005 Jul 14;436(7048):214-20 PMID: 15951802
  35. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis.
    Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16426-31 PMID: 16260724
  36. Silencing of microRNAs in vivo with 'antagomirs'.
    Nature. 2005 Dec 1;438(7068):685-9 PMID: 16258535
  37. A global map of p53 transcription-factor binding sites in the human genome.
    Cell. 2006 Jan 13;124(1):207-19 PMID: 16413492
  38. MicroRNAs as oncogenes.
    Curr Opin Genet Dev. 2006 Feb;16(1):4-9 PMID: 16361094
  39. Oncomirs - microRNAs with a role in cancer.
    Nat Rev Cancer. 2006 Apr;6(4):259-69 PMID: 16557279
  40. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.
    Cell. 2006 Mar 24;124(6):1169-81 PMID: 16564011
  41. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
    Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2014-24 PMID: 16609010
  42. Myogenic factors that regulate expression of muscle-specific microRNAs.
    Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8721-6 PMID: 16731620
  43. Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays.
    Cancer Res. 2006 Aug 15;66(16):7920-8 PMID: 16912165
  44. The p53 tumor suppressor participates in multiple cell cycle checkpoints.
    J Cell Physiol. 2006 Oct;209(1):13-20 PMID: 16741928
  45. MicroRNA signatures in human cancers.
    Nat Rev Cancer. 2006 Nov;6(11):857-66 PMID: 17060945
  46. A hexanucleotide element directs microRNA nuclear import.
    Science. 2007 Jan 5;315(5808):97-100 PMID: 17204650
  47. Processing of intronic microRNAs.
    EMBO J. 2007 Feb 7;26(3):775-83 PMID: 17255951
  48. CHD5 is a tumor suppressor at human 1p36.
    Cell. 2007 Feb 9;128(3):459-75 PMID: 17289567
  49. Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype.
    Am J Pathol. 2000 Nov;157(5):1623-31 PMID: 11073822
Article Info
Journal
Molecular cell
Abbr.
Mol Cell
ISSN
1097-2765
Published
2007-06-08
Epub
2007-00-31
Pages
745-52
Language
English
Region
United States
NLM ID
9802571
PMCID
PMC1939978
Subset
IM
Grants
NCI NIH HHS · R01CA113669 · United States
NCI NIH HHS · R01 CA120185 · United States
NCI NIH HHS · R01 CA113669-02 · United States
NCI NIH HHS · R01 CA120185-01A2 · United States
NCI NIH HHS · R01CA120185 · United States
NCI NIH HHS · R01 CA113669 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com